BR7506930A - Composto selecionado dentre compostos de 1 ariloxi-4-amino-2-butanol,composicao farmaceutica tendo atividade inibitoria de arritmia,processo de inibicao de arritmia cardiaca,e composto selecionado dentre os compostos de 1-ariloxi-4-cloro-2-butanol - Google Patents
Composto selecionado dentre compostos de 1 ariloxi-4-amino-2-butanol,composicao farmaceutica tendo atividade inibitoria de arritmia,processo de inibicao de arritmia cardiaca,e composto selecionado dentre os compostos de 1-ariloxi-4-cloro-2-butanolInfo
- Publication number
- BR7506930A BR7506930A BR7506930*A BR7506930A BR7506930A BR 7506930 A BR7506930 A BR 7506930A BR 7506930 A BR7506930 A BR 7506930A BR 7506930 A BR7506930 A BR 7506930A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- selected compound
- arthrity
- arritymia
- arilo
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 3
- 230000000747 cardiac effect Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51812274A | 1974-10-25 | 1974-10-25 | |
| US61898475A | 1975-10-02 | 1975-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR7506930A true BR7506930A (pt) | 1976-08-17 |
Family
ID=27059352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR7506930*A BR7506930A (pt) | 1974-10-25 | 1975-10-23 | Composto selecionado dentre compostos de 1 ariloxi-4-amino-2-butanol,composicao farmaceutica tendo atividade inibitoria de arritmia,processo de inibicao de arritmia cardiaca,e composto selecionado dentre os compostos de 1-ariloxi-4-cloro-2-butanol |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS6023100B2 (enExample) |
| AU (1) | AU507312B2 (enExample) |
| BR (1) | BR7506930A (enExample) |
| CA (1) | CA1077474A (enExample) |
| CH (1) | CH612907A5 (enExample) |
| DE (1) | DE2547570A1 (enExample) |
| DK (1) | DK154288C (enExample) |
| ES (1) | ES442077A1 (enExample) |
| FI (1) | FI60201C (enExample) |
| FR (2) | FR2289169A1 (enExample) |
| GB (1) | GB1520931A (enExample) |
| HU (1) | HU172525B (enExample) |
| IE (1) | IE43402B1 (enExample) |
| IL (1) | IL48309A (enExample) |
| IN (1) | IN142736B (enExample) |
| NL (1) | NL7512488A (enExample) |
| NO (1) | NO142666C (enExample) |
| NZ (1) | NZ178962A (enExample) |
| PH (2) | PH16403A (enExample) |
| SE (2) | SE434047B (enExample) |
| YU (1) | YU39950B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR920000799B1 (ko) * | 1987-12-11 | 1992-01-23 | 미쓰이 세끼유 가가꾸 고오교오 가부시끼가이샤 | 신규아민류 및 그 용도 |
| DE4108527A1 (de) * | 1991-03-15 | 1992-09-17 | Basf Ag | Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1245148A (en) * | 1968-11-18 | 1971-09-08 | Pfizer Ltd | Propanolamine derivatives |
| SE384853B (sv) * | 1972-04-04 | 1976-05-24 | Haessle Ab | Forfarande for framstellning av nya aminer |
| DE2001431C3 (de) * | 1970-01-06 | 1974-12-12 | Helopharm W. Petrik & Co Kg, 1000 Berlin | 2-(2'-Hydroxy-3'-alkylaminopropoxy)-Omega-phenyl-propiophenone und Verfahren zur Herstellung derselben |
| HU169464B (enExample) * | 1974-02-20 | 1976-11-28 |
-
1975
- 1975-10-15 IL IL48309A patent/IL48309A/xx unknown
- 1975-10-16 AU AU85778/75A patent/AU507312B2/en not_active Ceased
- 1975-10-16 NZ NZ178962A patent/NZ178962A/xx unknown
- 1975-10-20 CH CH1358275A patent/CH612907A5/xx not_active IP Right Cessation
- 1975-10-22 HU HU75RO00000864A patent/HU172525B/hu unknown
- 1975-10-22 PH PH17681A patent/PH16403A/en unknown
- 1975-10-23 GB GB43649/75A patent/GB1520931A/en not_active Expired
- 1975-10-23 FI FI752966A patent/FI60201C/fi not_active IP Right Cessation
- 1975-10-23 DE DE19752547570 patent/DE2547570A1/de not_active Ceased
- 1975-10-23 BR BR7506930*A patent/BR7506930A/pt unknown
- 1975-10-24 NO NO753575A patent/NO142666C/no unknown
- 1975-10-24 NL NL7512488A patent/NL7512488A/xx not_active Application Discontinuation
- 1975-10-24 DK DK480675A patent/DK154288C/da active
- 1975-10-24 YU YU2694/75A patent/YU39950B/xx unknown
- 1975-10-24 SE SE7511934A patent/SE434047B/xx not_active IP Right Cessation
- 1975-10-24 FR FR7532695A patent/FR2289169A1/fr active Granted
- 1975-10-24 ES ES442077A patent/ES442077A1/es not_active Expired
- 1975-10-24 CA CA238,243A patent/CA1077474A/en not_active Expired
- 1975-10-24 IE IE2328/75A patent/IE43402B1/en unknown
- 1975-10-25 JP JP50128804A patent/JPS6023100B2/ja not_active Expired
- 1975-12-30 IN IN2411/CAL/75A patent/IN142736B/en unknown
-
1976
- 1976-12-22 FR FR7638732A patent/FR2361888A1/fr active Granted
-
1979
- 1979-05-04 SE SE7903894A patent/SE449357B/sv not_active IP Right Cessation
-
1980
- 1980-10-02 PH PH24655A patent/PH16233A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR218848A1 (es) | Composicion de polimero-poliol y poliuretanos derivados de la misma | |
| AR226272A1 (es) | N-(1'-metoxicarboniletil)-n-metoxiacetil-2,6-dimetilanilina,composiciones fungicidas que la contienen y procedimiento para prepararla | |
| NL7613239A (nl) | Antimicrobieel en/of topicaal preparaat. | |
| AR224323A1 (es) | Composicion insecticida sinergizada que contiene crisantemato de n-(3,4,5,6-terahidroftalimido)-metilo o de 2-ali-3-metil-ciclopent-2-en-1-on-4-ilo y 3-fenoxibencil-2',2'-dimetil-3'-(2",2"-diclorovinil)-ciclopropanocarboxilato | |
| BG25087A3 (bg) | Метод за получаване на 2-тетрахидрофупфупил-6,7 бензоморфани и техните соли | |
| BR7605763A (pt) | Composicoes fungicidas e processo para preparacao das mesmas | |
| FI790726A7 (fi) | Välituote farmakologisesti aktiivisten yhdisteiden valmistamiseksi ja menetelmä välituotteen valmistamiseksi. | |
| AR204390A1 (es) | Procedimiento de preparacion de derivados de imidazolidinonas y perhidropirimidinonas n,n' bisustituidas | |
| AR210888A1 (es) | Procedimiento para la preparacion de nuevas benzamidas 2,4-disustituidas,2,5-disustituidas y 2,4,5-trisustituidas | |
| IT1051334B (it) | Composizione fungicida di uso agricolo | |
| ES454087A2 (es) | Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona nuevas. | |
| BR7506930A (pt) | Composto selecionado dentre compostos de 1 ariloxi-4-amino-2-butanol,composicao farmaceutica tendo atividade inibitoria de arritmia,processo de inibicao de arritmia cardiaca,e composto selecionado dentre os compostos de 1-ariloxi-4-cloro-2-butanol | |
| TR18255A (tr) | N-silfenillenmis 2,3-dihidrobenzofuranil-7-metil karbamatlar bunlarin hazirlanmasina mahsus usuller ve bunlarin ensekstisidler olarak kullanilmalari | |
| BR7503299A (pt) | Aduela de capeamento aperfeicoada e processo para execucao da mesma | |
| FR2283889A1 (fr) | Preparation d'hydrazodicarbonamide | |
| IT7825497A0 (it) | Derivati di 1,2,4-ossadiazolo, loro preparazione e loro applicazione in terapia. | |
| IT1143191B (it) | Composto di biureto 1,1,3,5-sostituito procedimento per prepararlo e composizione farmaceutica che lo contiene | |
| IT1091129B (it) | Composizione e procedimento per il trattamento di materiali cellulosici | |
| BR7700696A (pt) | Aplicacao de 2,4-dioxa-spiro(5,5)undec-8-enos,composicoes odoriferas contendo os mesmos,e compostos | |
| FI55609C (fi) | Foerfarande foer framstaellning av farmaceutiska kompositioner innehaollande 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxi-4,16,32,34,36-pentametyltetrakonta-16,32-dien-35-0-lakton-40-guanidiniumsulfat (debrycin) | |
| IT8048966A0 (it) | Composizione farmaceutica contenente allopurinolo e procedimento di preparazione | |
| BE828696A (fr) | Preparation de 3-trichloromethyl-5-alkoxy inferieur-1,2,4-thiadiazole | |
| NL190573C (nl) | Farmaceutisch preparaat met diuretische, antihypertensieve en cardiale werking, alsmede 2,4,7-triamino-6-fenylpteridineverbindingen. | |
| BR7807425A (pt) | 2,4-diamino-5-benzil-pirimidinas processo para sua preparacao,preservacoes farmaceuticas,aplicacao das ditas benzil-pirimidinas e aldeidos | |
| TR18100A (tr) | 2,4-dienoksi-6 (alkoksililalkilamino)-striazinlerin imaline mahsus usul ve bunlarin kullanilmasi |